Basic & Clinical Medicine ›› 2020, Vol. 40 ›› Issue (10): 1335-1341.

• Original Articles • Previous Articles     Next Articles

GPRC5A promotes migration and invasion of human osteosarcoma cell line 143B

SONG Qi1, CHENG An-yuan1, YU Ling2, XU Li1*   

  1. 1. Department of Orthopedics, the First Hospital of Wuhan, Wuhan 430022;
    2. Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan 430060,China
  • Received:2020-05-08 Revised:2020-07-28 Online:2020-10-05 Published:2020-09-29
  • Contact: * drxuli2020@126.com

Abstract: Objective To investigate the effect and mechanism of GPRC5A (G protein-coupled receptor family C, member 5, group A) gene on the migration and invasion of osteosarcoma cell line 143B. Methods Differentially expressed genes in metastatic tumors were screened out from the GSE32981 data set, and the survival analysis of the differentially expressed genes was performed in combination with the TCGA database. CCK8 experiment, scratch experiment and Transwell invasion experiment were carried out to detect the effect of GPRC5A knockdown or overexpression on osteosarcoma cell proliferation, migration and invasion. Western blot and RT-qPCR detected the effect of GPRC5A knockdown or over-expression on protein and mRNA levels of EMT related genes. Results The expression of 299 genes was changed in metastatic osteosarcoma, and 37 genes closely related to the survival of osteosarcoma patients were further screened out combined with TCGA database. The results of cell experiments showed that GPRC5A had no effect on the proliferation of osteosarcoma cells, but GPRC5A over-expression could significantly promote osteosarcoma cells migration and invasion(P<0.05). GPRC5A overexpression promoted the expression of EMT-related proteins N-Cad and Vim, and inhibited the expression of E-Cad(P<0.05). Conclusions GPRC5A is closely related to the survival of osteosarcoma patients and may promote the migration and invasion of osteosarcoma cells by inducing EMT, so it is believed to be a potential target for anti-osteosarcoma metastasis drugs.

Key words: GPRC5A, osteosarcoma, bioinformatics, public database

CLC Number: